Literature DB >> 7110507

Inhibition of foot intake in the rat.

N Blavet, F V DeFeudis.   

Abstract

The effects of single oral administrations of tricyclic antidepressants (imipramine and desipramine), an atypical antidepressant (nomifensine), known anorexic agents, haloperidol, and diazepam on food intake were compared in Sprague-Dawley rats over a 4-day test period. The tricyclic antidepressants produced decreases in food intake during the total 4-day test period following their administration. In contrast, the anorexic agents (d-amphetamine, cocaine, mazindol, fenfluramine and quipazine), and nomifensine, and haloperidol produced decreases in food intake only on their administration. Diazepam produced an increase in food intake only on the day of its decrease food intake, this model appears to show some specificity for tricyclic antidepressants.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7110507     DOI: 10.1007/bf00965645

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  37 in total

1.  Central GABA-ergic systems and feeding behavior.

Authors:  F V Defeudis
Journal:  Neurochem Int       Date:  1981       Impact factor: 3.921

2.  Weight changes with schizophrenic psychosis and psychotropic drug therapy.

Authors:  J M Holden; U P Holden
Journal:  Psychosomatics       Date:  1970 Nov-Dec       Impact factor: 2.386

3.  [8-amino-4-phenyl-1,2,3,4-tetrahydroisoquinolines, a new group of antidepressive psycholeptic drugs].

Authors:  I Hoffmann; G Ehrhart; K Schmitt
Journal:  Arzneimittelforschung       Date:  1971-07

4.  A simple and specific screen for benzodiazepine-like drugs.

Authors:  B P Poschel
Journal:  Psychopharmacologia       Date:  1971

Review 5.  The mechanism of action of fenfluramine.

Authors:  S Garattini; W Buczko; A Jori; R Samanin
Journal:  Postgrad Med J       Date:  1975       Impact factor: 2.401

6.  Pharmacological and biochemical studies with three metabolites of nomifensine.

Authors:  H Kruse; I Hoffmann; H J Gerhards; M Leven; U Schacht
Journal:  Psychopharmacology (Berl)       Date:  1977-01-31       Impact factor: 4.530

7.  Further characterization of the behavioral despair test in mice: positive effects of convulsants.

Authors:  C Betin; F V DeFeudis; N Blavet; F Clostre
Journal:  Physiol Behav       Date:  1982-02

8.  Evidence for a difference in mechanism of action between fenfluramine- and amphetamine-induced anorexia.

Authors:  S Jespersen; J Scheel-Krüger
Journal:  J Pharm Pharmacol       Date:  1973-01       Impact factor: 3.765

9.  Nomifensine: a new potent inhibitor of dopamine uptake into synaptosomes from rat brain corpus striatum.

Authors:  P Hunt; M Kannengiesser; J Raynaud
Journal:  J Pharm Pharmacol       Date:  1974-05       Impact factor: 3.765

10.  Cocaine tachyphylaxis and effects on indirectly-acting sympathomimetic drugs in the rabbit aortic strip and in splenic tissue.

Authors:  G D Maengwyn-Davies; T Koppanyi
Journal:  J Pharmacol Exp Ther       Date:  1966-12       Impact factor: 4.030

View more
  4 in total

Review 1.  Pharmacological approaches for the treatment of obesity.

Authors:  José-Antonio Fernández-López; Xavier Remesar; Màrius Foz; Marià Alemany
Journal:  Drugs       Date:  2002       Impact factor: 9.546

2.  Desipramine and restraint stress induce odor conditioned aversion in rats: suppression by repeated conditioning.

Authors:  V S Murua; V A Molina
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

3.  Effects of ICV administration of the alpha1A-adrenoceptor antagonist 5-methylurapidil on concurrent measures of eating and locomotion after cocaine in the rat.

Authors:  P Shane Clifford; Kristina W Davis; Audrea E Elliott; Paul J Wellman
Journal:  Life Sci       Date:  2007-08-17       Impact factor: 5.037

4.  Effects of chronic oral administration of the antidepressants, desmethylimipramine and zimelidine on rat cortical GABAB binding sites: a comparison with 5-HT2 binding site changes.

Authors:  J A Cross; R W Horton
Journal:  Br J Pharmacol       Date:  1988-02       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.